Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Josse, R. G."" wg kryterium: Autor


Tytuł :
Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study.
Autorzy :
Bliuc D; Osteoporosis and Bone Biology, Garvan Institute of Medical Research, Sydney, Australia. .
Tran T; Osteoporosis and Bone Biology, Garvan Institute of Medical Research, Sydney, Australia.
van Geel T; Maastricht University Medical Center, Research School CAPHRI, Care and Public Health Research Institute, Maastricht, The Netherlands.
Adachi JD; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Berger C; CaMos National Coordinating Centre, McGill University, Montreal, Quebec, Canada.
van den Bergh J; Research School Nutrim, Department of Internal Medicine, Subdivision of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands.; Department of Internal Medicine, VieCuri Medical Centre of Noord-Limburg, Venlo, The Netherlands.
Eisman JA; Osteoporosis and Bone Biology, Garvan Institute of Medical Research, Sydney, Australia.; School of Medicine Sydney, University of Notre Dame Australia, Sydney, Australia.
Geusens P; Maastricht University Medical Center, Research School CAPHRI, Care and Public Health Research Institute, Maastricht, The Netherlands.; Biomedical Research Institute, University Hasselt, Hasselt, Belgium.
Goltzman D; Department of Medicine, McGill University, Montreal, Quebec, Canada.
Hanley DA; Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
Josse RG; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Kaiser S; Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
Kovacs CS; Faculty of Medicine, Memorial University, St. John's, Newfoundland, Canada.
Langsetmo L; School of Public Health, University of Minnesota, Twin Cities, Minneapolis, MN, USA.
Prior JC; Department of Medicine and Endocrinology, University of British Columbia, Vancouver, British Columbia, Canada.
Nguyen TV; Osteoporosis and Bone Biology, Garvan Institute of Medical Research, Sydney, Australia.; Clinical School, Faculty of Medicine, St Vincent's Hospital, UNSW, Sydney, Australia.; School of Biomedical Engineering, University of Technology Sydney, Sydney, Australia.
Center JR; Osteoporosis and Bone Biology, Garvan Institute of Medical Research, Sydney, Australia.; Clinical School, Faculty of Medicine, St Vincent's Hospital, UNSW, Sydney, Australia.
Pokaż więcej
Corporate Authors :
CaMOS Research Group
Źródło :
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2019 Apr; Vol. 30 (4), pp. 817-828. Date of Electronic Publication: 2019 Jan 03.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study
MeSH Terms :
Bone Density Conservation Agents/*therapeutic use
Diphosphonates/*therapeutic use
Osteoporosis/*drug therapy
Osteoporotic Fractures/*prevention & control
Aged ; Alendronate/therapeutic use ; Canada/epidemiology ; Etidronic Acid/therapeutic use ; Female ; Follow-Up Studies ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Osteoporosis/mortality ; Osteoporotic Fractures/mortality ; Prospective Studies ; Risedronic Acid/therapeutic use ; Risk Factors ; Risk Reduction Behavior
Czasopismo naukowe
Tytuł :
The association between sclerostin and incident type 2 diabetes risk: a cohort study.
Autorzy :
Yu OH; Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada.; Division of Endocrinology, Jewish General Hospital, Montreal, QC, Canada.
Richards B; Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada.; Division of Endocrinology, Jewish General Hospital, Montreal, QC, Canada.
Berger C; CaMos Coordinating Centre, McGill University, Montreal, QC, Canada.
Josse RG; Division of Endocrinology & Metabolism, St Michael's University of Toronto, Toronto, ON, Canada.
Leslie WD; Department of Medicine, University of Manitoba, Winnipeg, MB, Canada.
Goltzman D; Department of Medicine, McGill University and McGill University Health Centre, Montreal, QC, Canada.
Kaiser SM; Division of Endocrinology & Metabolism, Dalhousie University, Halifax, NS, Canada.
Kovacs CS; Discipline of Medicine-Endocrinology, Memorial University of Newfoundland, St. John's, NL, Canada.
Davison KS; A Priori Medical Sciences Inc., Victoria, BC, Canada.
Pokaż więcej
Źródło :
Clinical endocrinology [Clin Endocrinol (Oxf)] 2017 Apr; Vol. 86 (4), pp. 520-525. Date of Electronic Publication: 2017 Jan 26.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Bone Morphogenetic Proteins/*blood
Diabetes Mellitus, Type 2/*blood
Adaptor Proteins, Signal Transducing ; Aged ; Canada ; Cohort Studies ; Fasting/blood ; Genetic Markers ; Homeostasis ; Humans ; Incidence ; Insulin/blood ; Insulin Resistance ; Middle Aged ; Risk
Czasopismo naukowe
Tytuł :
Salba-chia (Salvia hispanica L.) in the treatment of overweight and obese patients with type 2 diabetes: A double-blind randomized controlled trial.
Autorzy :
Vuksan V; Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital, Toronto, ON, Canada; Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada; Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Division of Endocrinology & Metabolism, St. Michael's Hospital, Toronto, ON, Canada. Electronic address: .
Jenkins AL; Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital, Toronto, ON, Canada.
Brissette C; Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital, Toronto, ON, Canada; Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Choleva L; Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital, Toronto, ON, Canada; Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Jovanovski E; Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital, Toronto, ON, Canada; Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Gibbs AL; Department of Statistical Sciences, University of Toronto, Toronto, ON, Canada.
Bazinet RP; Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Au-Yeung F; Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital, Toronto, ON, Canada; Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Zurbau A; Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital, Toronto, ON, Canada; Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Ho HV; Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital, Toronto, ON, Canada; Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Duvnjak L; Vuk Vrhovac Clinic for Diabetes, Endocrinology and Metabolic Diseases, University Hospital Merkur, University of Zagreb, School of Medicine, Zagreb, Croatia.
Sievenpiper JL; Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital, Toronto, ON, Canada; Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada; Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Division of Endocrinology & Metabolism, St. Michael's Hospital, Toronto, ON, Canada.
Josse RG; Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada; Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Division of Endocrinology & Metabolism, St. Michael's Hospital, Toronto, ON, Canada.
Hanna A; Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Division of Endocrinology & Metabolism, St. Michael's Hospital, Toronto, ON, Canada.
Pokaż więcej
Źródło :
Nutrition, metabolism, and cardiovascular diseases : NMCD [Nutr Metab Cardiovasc Dis] 2017 Feb; Vol. 27 (2), pp. 138-146. Date of Electronic Publication: 2016 Dec 09.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Caloric Restriction*
Diet, Reducing*
Salvia*
Seeds*
Weight Loss*
Diabetes Mellitus, Type 2/*complications
Obesity/*diet therapy
Adiposity ; Diabetes Mellitus, Type 2/diagnosis ; Double-Blind Method ; Female ; Humans ; Male ; Middle Aged ; Obesity/complications ; Obesity/diagnosis ; Obesity/physiopathology ; Ontario ; Phytotherapy ; Plants, Medicinal ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Retraction to: Nitrate use and changes in bone mineral density: the Canadian Multicentre Osteoporosis Study.
Autorzy :
Jamal SA; Medicine, University of Toronto, Toronto, ON, Canada. .; 76 Grenville Street, Suite 805, Toronto, ON, M5S 1B2, Canada. .
Goltzman D; Medicine, McGill University, Montreal, PQ, Canada.
Hanley DA; Medicine, University of Calgary, Calgary, AB, Canada.
Papaioannou A; Medicine, McMaster University, Hamilton, ON, Canada.
Prior JC; Medicine, University of British Columbia, Vancouver, BC, Canada.
Josse RG; Medicine, University of Toronto, Toronto, ON, Canada.
Pokaż więcej
Źródło :
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2017 Jan; Vol. 28 (1), pp. 421.
Typ publikacji :
Journal Article; Retraction of Publication
Czasopismo naukowe
Tytuł :
Direct comparison of FRAX(R) and a simplified fracture risk assessment tool in routine clinical practice: a registry-based cohort study.
Autorzy :
Leslie WD; University of Manitoba, Winnipeg, Canada. .; Department of Medicine (C5121), St. Boniface Hospital, 409 Tache Avenue, Winnipeg, MB, R2H 2A6, Canada. .
Majumdar SR; University of Alberta, Edmonton, Canada.
Lix LM; University of Manitoba, Winnipeg, Canada.
Josse RG; University of Toronto, Toronto, Canada.
Johansson H; Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, UK.
Oden A; Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, UK.
McCloskey EV; Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, UK.
Kanis JA; Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, UK.
Pokaż więcej
Źródło :
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2016 Sep; Vol. 27 (9), pp. 2689-2695. Date of Electronic Publication: 2016 Apr 23.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Bone Density*
Risk Assessment*
Osteoporotic Fractures/*diagnosis
Aged ; Cohort Studies ; Densitometry ; Female ; Humans ; Male ; Manitoba ; Middle Aged ; Registries ; Risk Factors
Czasopismo naukowe
Tytuł :
Associations of Protein Intake and Protein Source with Bone Mineral Density and Fracture Risk: A Population-Based Cohort Study.
Autorzy :
Langsetmo L; David Goltzman, Royal Victoria Hospital, CaMos, 687 Pine Ave W, Room E1.64, Montreal, QC H3A 1A1, Email: , Telephone: 514-843-1632, FAX: 514-843-1651.
Barr SI
Berger C
Kreiger N
Rahme E
Adachi JD
Papaioannou A
Kaiser SM
Prior JC
Hanley DA
Kovacs CS
Josse RG
Goltzman D
Pokaż więcej
Corporate Authors :
CaMos Research Group
Źródło :
The journal of nutrition, health & aging [J Nutr Health Aging] 2015 Oct; Vol. 19 (8), pp. 861-8.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Dietary Proteins*
Energy Intake*
Bone Density/*physiology
Osteoporosis/*epidemiology
Osteoporotic Fractures/*epidemiology
Adult ; Animals ; Canada/epidemiology ; Cohort Studies ; Diet ; Female ; Humans ; Lumbar Vertebrae/physiology ; Male ; Middle Aged ; Premenopause ; Prospective Studies ; Risk ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł :
Characteristics of hyperparathyroid states in the Canadian multicentre osteoporosis study (CaMos) and relationship to skeletal markers.
Autorzy :
Berger C; CaMos Coordinating Centre, McGill University, Montreal, QC, Canada.
Almohareb O
Langsetmo L
Hanley DA
Kovacs CS
Josse RG
Adachi JD
Prior JC
Towheed T
Davison KS
Kaiser SM
Brown JP
Goltzman D
Pokaż więcej
Corporate Authors :
CaMos Research Group
Źródło :
Clinical endocrinology [Clin Endocrinol (Oxf)] 2015 Mar; Vol. 82 (3), pp. 359-68. Date of Electronic Publication: 2014 Sep 01.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Hyperparathyroidism, Primary/*blood
Hyperparathyroidism, Primary/*metabolism
Hyperparathyroidism, Secondary/*blood
Hyperparathyroidism, Secondary/*metabolism
Biomarkers/blood ; Biomarkers/metabolism ; Bone Density/physiology ; Calcium/blood ; Canada ; Cross-Sectional Studies ; Humans ; Hyperparathyroidism, Primary/physiopathology ; Hyperparathyroidism, Secondary/physiopathology ; Immunoassay ; Osteoporosis/blood ; Osteoporosis/metabolism ; Osteoporosis/physiopathology ; Vitamin D/analogs & derivatives ; Vitamin D/blood
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies